Source
13 developments in the corpus
Latest
Everything in the corpus, newest first.
OCT 23, 2026 · JOURNAL ARTICLE
Molecular Biomedicine
Abstract There is a critical need to identify validated biomarkers that can predict cancer patient outcomes. This study evaluated biomarkers of neutrophil extracellular traps (NETs
Abstract Sirtuins (SIRT1–SIRT7) are evolutionarily conserved NAD + -dependent deacylases that function as metabolic sensors, coupling cellular metabolic state to epigenetic, transc
OCT 23, 2026 · JOURNAL ARTICLE
Molecular Biomedicine
Abstract Type 1 diabetes mellitus (T1DM) is characterized by the destruction of pancreatic β-cells, in which the dysfunction of regulatory T cells (Tregs) contributes to impaired i
OCT 15, 2026 · JOURNAL ARTICLE
Molecular Biomedicine
Abstract Chronic colitis is a major risk factor for colorectal cancer (CRC), particularly for colitis-associated colorectal cancer (CAC), where persistent inflammation drives the t
OCT 14, 2026 · JOURNAL ARTICLE
Molecular Biomedicine
Abstract The role of gut microbiota and their metabolites in the progression of hepatocellular carcinoma (HCC) has garnered increasing attention. Although Alistipes, a genus freque
OCT 10, 2026 · JOURNAL ARTICLE
Molecular Biomedicine
Abstract The infiltration of tumors by CD8⁺ T lymphocytes is a critical determinant of antitumor immunity and response to immunotherapy. However, the presence of tumor-specific CD8
Abstract Bile acids (BAs), cholesterol-derived amphipathic metabolites which are traditionally regarded as digestive surfactants, are now recognized as pleiotropic signaling molecu
SEP 22, 2026 · JOURNAL ARTICLE
Molecular Biomedicine
Abstract While dietary therapies targeting individual amino acids in cancer show promise in modulating tumor metabolism, the issue of nutrient competition between tumors and the im